Teradyne (TER) Tops Q1 EPS by 48c, provides guidance

Teradyne (NASDAQ: TER) reported Q1 EPS of $2.56, $0.48 better than the analyst estimate of $2.08. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.19 billion.

GUIDANCE:

Teradyne sees Q2 2026 EPS of $1.86-$2.15, versus the consensus of $1.96. Teradyne sees Q2 2026 revenue of $1.15-1.25 billion, versus the consensus of $1.193 billion.

For earnings history and earnings-related data on Teradyne (TER) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c